Patents by Inventor Ji Yeong Gal

Ji Yeong Gal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrrolidine and piperidine compounds
    Patent number: 11655235
    Abstract: The present technology provides pyrrolidine and piperidine compounds or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and uses thereof. In particular, said compounds may be usefully applied in the treatment and prevention of FAP-mediated diseases.
    Type: Grant
    Filed: November 5, 2020
    Date of Patent: May 23, 2023
    Assignee: YUHAN CORPORATION
    Inventors: Tae Han Dong, Yoo Hoi Park, Tae Kyun Kim, Jae Eun Joo, Eun Hye Jung, Jae Won Jeong, Hyun Seung Lee, Do Hoon Kim, Ji Eun Yang, Jun Chui Park, Sang Myoun Lim, Na Ry Ha, Da In Chung, Ji Yeong Gal
  • PYRROLIDINE AND PIPERIDINE COMPOUNDS
    Publication number: 20210147386
    Abstract: The present technology provides pyrrolidine and piperidine compounds or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and uses thereof. In particular, said compounds may be usefully applied in the treatment and prevention of FAP-mediated diseases.
    Type: Application
    Filed: November 5, 2020
    Publication date: May 20, 2021
    Inventors: Tae Han DONG, Yoo Hoi PARK, Tae Kyun KIM, Jae Eun JOO, Eun Hye Jung, Jae Won JEONG, Hyun Seung LEE, Do Hoon KIM, Ji Eun YANG, Jun Chul PARK, Sang Myoun LIM, Na Ry HA, Da In CHUNG, Ji Yeong GAL
  • Quinazoline derivative or its salt and pharmaceutical composition comprising the same
    Patent number: 10941136
    Abstract: The present invention provides a quinazoline derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, a pharmaceutical composition comprising the same and a use thereof. The quinazoline derivative or its pharmaceutically acceptable salt has a selective inhibitory activity against the phosphatidylinositol 3-kinase delta subunit, and therefore can be usefully applied for preventing or treating cancer, along with avoiding side effects such as lymphopenia-associated inflammatory responses.
    Type: Grant
    Filed: April 26, 2017
    Date of Patent: March 9, 2021
    Assignee: YUHAN CORPORATION
    Inventors: Young-Hwan Kim, Tae-Dong Han, Dong-Hoon Kim, Eun-Hye Jung, Su-Bin Choi, Eui-Chul Lee, Won-Ee Chong, Jin-Hwi Park, Jun-Chul Park, Ho-Woong Kang, Ji-Yeong Gal, Chan-Sun Park, Jong-Gyun Kim, Su-Youn Nam
  • QUINAZOLINE DERIVATIVE OR ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
    Publication number: 20200325120
    Abstract: The present invention provides a quinazoline derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, a pharmaceutical composition comprising the same and a use thereof. The quinazoline derivative or its pharmaceutically acceptable salt has a selective inhibitory activity against the phosphatidylinositol 3-kinase delta subunit, and therefore can be usefully applied for preventing or treating cancer, along with avoiding side effects such as lymphopenia-associated inflammatory responses.
    Type: Application
    Filed: April 26, 2017
    Publication date: October 15, 2020
    Applicant: YUHAN CORPORATION
    Inventors: Young-Hwan KIM, Tae-Dong HAN, Dong-Hoon KIM, Eun-Hye JUNG, Su-Bin CHOI, Eui-Chul LEE, Won-Ee CHONG, Jin-Hwi PARK, Jun-Chul PARK, Ho-Woong KANG, Ji-Yeong GAL, Chan-Sun PARK, Jong-Gyun KIM, Su-Youn NAM
  • Fused ring compound containing furan or salt thereof and pharmaceutical composition comprising same
    Patent number: 9493478
    Abstract: The present invention provides a fused ring compound containing furan or a pharmaceutically acceptable salt thereof, a method for preparing same, a pharmaceutical composition comprising same, and a use thereof. The fused ring compound containing furan or a pharmaceutically acceptable salt thereof inhibits the activity of phosphatidylinositol 3-kinase (PI3K) and can therefore be used in a pharmaceutical composition for treating and preventing respiratory diseases, inflammatory diseases, proliferative diseases, cardiovascular diseases, or central nervous system diseases which occur due to the over-activation of PI3K.
    Type: Grant
    Filed: July 23, 2013
    Date of Patent: November 15, 2016
    Assignee: YUHAN CORPORATION
    Inventors: Hyoung Sig Seo, Tae Kyun Kim, Hyun Joo Lee, Dong Hoon Kim, Gyu Jin Lee, Jun Chul Park, Ji Yeong Gal, Tae-hoon Kim, Kwan Hoon Hyun, Kyoung Kyu Ahn, Kaapjoo Park, Su Youn Nam, Ge Hyeong Lee, Hee Jong Lim
  • FUSED RING COMPOUND CONTAINING FURAN OR SALT THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
    Publication number: 20150191478
    Abstract: The present invention provides a fused ring compound containing furan or a pharmaceutically acceptable salt thereof, a method for preparing same, a pharmaceutical composition comprising same, and a use thereof. The fused ring compound containing furan or a pharmaceutically acceptable salt thereof inhibits the activity of phosphatidylinositol 3-kinase (PI3K) and can therefore be used in a pharmaceutical composition for treating and preventing respiratory diseases, inflammatory diseases, proliferative diseases, cardiovascular diseases, or central nervous system diseases which occur due to the over-activation of PI3K.
    Type: Application
    Filed: July 23, 2013
    Publication date: July 9, 2015
    Applicant: YUHAN CORPORATION
    Inventors: Hyoung Sig Seo, Tae Kyun Kim, Hyun Joo Lee, Dong Hoon Kim, Gyu Jin Lee, Jun Chul Park, Ji Yeong Gal, Tae-hoon Kim, Kwan Hoon Hyun, Kyoung Kyu Ahn, Kaapjoo Park, Su Youn Nam, Ge Hyeong Lee, Hee Jong Lim